Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:20 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | THIRD ROCK VENTURES LP | 164,190 0.3% | -2,869,893 (-94.59%) | View |
| 2021-02-16 4:13 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | GREAT POINT PARTNERS LLC | 1,024,800 2.15% | -1,276,657 (-55.47%) | View |
| 2021-02-16 3:18 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | Bain Capital Life Sciences Fund L.P. | 1,270,003 2.7% | -1,291,347 (-50.42%) | View |
| 2021-02-16 3:11 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management LP | 0 0% | -2,300,000 (Position Closed) | View |
| 2021-02-12 6:14 pm Unchanged | 13G | CONSTELLATION PHARMACEUTICALS CNST | COLUMN GROUP L P | 6,240,638 13.1% | 0 (Unchanged) | View |
| 2021-02-12 08:01 am Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | Avoro Capital Advisors LLC | 2,950,000 6.2% | -700,000 (-19.18%) | View |
| 2021-02-04 11:19 am Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | WELLINGTON MANAGEMENT GROUP LLP | 4,394,543 9.24% | 4,394,543 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | BlackRock Inc. BLK | 2,596,599 5.5% | 2,596,599 (New Position) | View |
| 2021-02-01 3:35 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 1.536% | -1,010,000 (-57.80%) | View |
| 2020-06-24 4:15 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | COLUMN GROUP L P | 6,240,638 13.1% | 41,674 (+0.67%) | View |
| 2020-06-05 5:00 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | GREAT POINT PARTNERS LLC | 2,301,457 5.5% | 2,301,457 (New Position) | View |
| 2020-02-14 5:02 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,747,406 21% | -550,000 (-23.94%) | View |
| 2020-02-14 4:06 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | VENROCK ASSOCIATES V LP | 4,016,873 9.7% | 400,000 (+11.06%) | View |
| 2020-02-14 4:02 pm Unchanged | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management LP | 2,300,000 5.52% | 0 (Unchanged) | View |
| 2020-02-14 10:15 am Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | Avoro Capital Advisors LLC | 3,650,000 8.8% | 3,650,000 (New Position) | View |
| 2020-02-07 11:16 am Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | FMR LLC | 1,581,715 3.856% | 7,270 (+0.46%) | View |
| 2020-02-06 5:26 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | Casdin Capital LLC | 1,212,734 2.9% | -344,265 (-22.11%) | View |
| 2019-11-18 4:28 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management LP | 2,300,000 5.21% | 1,028,313 (+80.86%) | View |
| 2019-10-11 4:36 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | Bain Capital Life Sciences Fund L.P. | 2,561,350 7.7% | 2,561,350 (New Position) | View |
| 2019-10-10 4:55 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | COLUMN GROUP L P | 6,198,964 18.5% | 1,490,919 (+31.67%) | View |